April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Assessment of the Outcome of Ophthalmological Screening of Children with Juvenile Idiopathic Arthritis
Author Affiliations & Notes
  • Maria Papadopoulou
    Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden
  • Madeleine Zetterberg
    Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden
    Institute of Neuroscience and Physiology /Ophthalmology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
  • Solveig Oskarsdottir
    Department of Pediatric Immunology and Rheumatology, The Queen Silvia Children, Gothenburg, Sweden
  • Marita Andersson Grönlund
    Institute of Neuroscience and Physiology /Ophthalmology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
  • Footnotes
    Commercial Relationships Maria Papadopoulou, None; Madeleine Zetterberg, None; Solveig Oskarsdottir, None; Marita Andersson Grönlund, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4488. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Papadopoulou, Madeleine Zetterberg, Solveig Oskarsdottir, Marita Andersson Grönlund; Assessment of the Outcome of Ophthalmological Screening of Children with Juvenile Idiopathic Arthritis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4488.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The group under study is comprised of all children with juvenile idiopathic arthritis (JIA) who has been screened for uveitis at the Queen Silvia Children's Hospital, Gothenburg, Sweden between 2002 and 2011. The aims were 1) to describe the JIA-subgroups as defined by the International League of Associations for Rheumatology (ILAR) criteria, 2) to describe the children developing uveitis in order to find possible predictors for risk of uveitis and 3) to determine the 5-year-incidence and the complications of uveitis in this JIA-population.

Methods: Medical records of 299 children with JIA during 10 years were analyzed retrospectively.

Results: The children were categorized in the following JIA-subgroups as defined by the International League of Associations for Rheumatology (ILAR) criteria: oligoarthritis (n=172; 57%), RF(-) polyarthritis (PA) (n=63; 21%), RF(+) PA (n=10; 3%), systemic (n=12; 4%), enthesitis-related (n=17; 5%), psoriatic (n=20; 6%) and undifferentiated (n=5; 2%). Uveitis was found in 11% of the JIA-group (32/299), bilateral uveitis was found in 25 children (78%). Oligoarthritis was most prevalent (n=24), followed by RF(-) PA (n=7) and systemic (n=1). 31/32 children were found to be ANA(+) (totally 54%). Sex ratio was 3.5:1 (girls:boys). The mean age of arthritis onset in children who developed uveitis was 3.5 years (range 1-10). In one girl uveitis was diagnosed before the onset of arthritis. The mean time interval between diagnosis of arthritis and uveitis was 17 months (range 1-60). The 5-year-incidence of uveitis was 19.7% (15/76 completed a 5-year follow-up). Of all 32 children, only one developed uveitis between the 4th and the 5th year after arthritis onset . The following complications were noted: posterior synechiae (37%), ocular hypertension (25%), cataract (19%), band keratopathy (15%), secondary glaucoma (9%), vitritis (9%), macular oedema (3%) and blindness in one eye (3%). 13 eyes of 8 children required eye surgery for uveitis complications.

Conclusions: Most of the epidemiological characteristics found in the present study are in accordance with previous studies. The vast majority (96%) of our JIA-group developed uveitis within the first four years after arthritis onset, a fact that accentuates the importance of early initiation of ophthalmological screening and more frequent regular follow-up examinations within the first four years after arthritis onset.

Keywords: 463 clinical (human) or epidemiologic studies: prevalence/incidence • 464 clinical (human) or epidemiologic studies: risk factor assessment • 462 clinical (human) or epidemiologic studies: outcomes/complications  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×